Finoriq research workspace
Medpace Holdings, Inc. (MEDP) SEC Filings & Filing Highlights
Medpace Holdings, Inc. provides clinical research-based drug and medical device development. Review MEDP SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
- Company
- Medpace Holdings, Inc. (MEDP)
- Ticker
- MEDP
- Market Cap
- $15.1B
- Latest Price
- $528.8
- Industry
- Biotech & Pharma
Medpace Holdings, Inc. (MEDP) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Medpace Holdings, Inc. (MEDP).
| Event | Form | Date |
|---|---|---|
| Effective June 1, 2026, Medpace Holdings, Inc. (the “Company”) appointed Brad W. Hansman, age 4...Effective June 1, 2026, Medpace Holdings, Inc. (the “Company”) appointed Brad W. Hansman, age 43, to the position of Executive Vice Preside... | 8-K5.02 | 2026-06-04 |
| On May 15, 2026, the Company held its 2026 Annual MeetingOn May 15, 2026, the Company held its 2026 Annual Meeting | 8-K5.07 | 2026-05-19 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-05-19 |
| On April 21, 2026, Jesse Geiger notified the Company of his intent to resign as President and t...On April 21, 2026, Jesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effectiv... | 8-K5.02 | 2026-04-22 |
| Medpace Holdings, Inc.: Earnings or resultsOn April 22, 2026, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ende... | 8-K2.02 | 2026-04-22 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.